Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00478712 · ClinicalTrials.gov registry record
Hirschsprung Disease Genetic Study
A clinical trial of Hirschsprung Disease, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- 3,000
- Enrollment target
- 1
- Study location
NCT00478712: Recruiting study of Hirschsprung Disease, sponsored by NYU Langone Health.
NCT00478712 is a study of Hirschsprung Disease that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 3,000 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00478712, a study of Hirschsprung Disease, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- 3,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Hirschsprung disease is a genetic condition caused by lack of nerve cells in varying lengths of the intestines. This study will investigate the complex genetic basis of the disease, which involves multiple interacting genetic factors.
Primary Outcome
Genome-wide assays of common genetic variation will be assessed using single nucleotide polymorphism (SNP) arrays
Conditions Studied
Interventions
- OTHER Identification of genetic causes of Hirschsprung Disease
Study Locations (1)
New York
- New York University School of Medicine - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2001-01 |
| Est. Completion | 2028-12 |
What NCT00478712 shows while recruiting
NCT00478712 is an observational study that tracks outcomes without assigning an intervention. Its 3,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Hirschsprung Disease appearing as the primary indexed condition, and to 1 intervention - of which Identification of genetic causes of Hirschsprung Disease is the first listed.
NCT00478712 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00478712 about?
NCT00478712 is a clinical study titled "Hirschsprung Disease Genetic Study". Hirschsprung disease is a genetic condition caused by lack of nerve cells in varying lengths of the intestines. This study will investigate the complex genetic basis of the disease, which involves multiple interacting genetic factors.
What is the current status of trial NCT00478712?
This trial is currently recruiting. The enrollment target is 3,000 participants. The study started on 2001-01. Estimated completion is 2028-12.
What conditions does trial NCT00478712 study?
This clinical trial studies the following conditions: Hirschsprung Disease.
What interventions are being tested in trial NCT00478712?
The interventions under investigation include: Identification of genetic causes of Hirschsprung Disease (OTHER).
Who is sponsoring clinical trial NCT00478712?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00478712 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hirschsprung Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004847 · 3,000 participants · Phase 1
Diagnosis of Pheochromocytoma
- NCT00579566 · 3,000 participants
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
- NCT00816114 · 3,000 participants
Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
- NCT01205815 · 3,000 participants
Storage and Research Use of Human Bio-specimens From Melanoma Patients and Clinical Testing for Assignment of Treatment
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia